Opiate Addictions

Titan Receives Notice Of Allowance For Probuphine(R) Patent Application In The Treatment Of Opiate Addiction (Medical News Today)

December 8th, 2009

More info…
Titan Pharmaceuticals, Inc (Pink Sheets:TTNP) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan’s United States patent application directed to the use of Probuphine for the treatment of opiate addiction. The patent application is U.S. Application No. 10/453,377 filed June 2, 2003 titled “Implantable polymeric device for sustained …

opiate detox

Posted in Opiate Addictions | Comments (0)

Leave a Reply

Name (required)

Mail (will not be published) (required)

Website

Security Code:

Categories

• Opiate Addiction Treatment
• Opiate Addictions
• Opiate Detox
• Opiate Withdrawal

Archives

• September 2010
• August 2010
• July 2010
• June 2010
• May 2010
• April 2010
• March 2010
• February 2010
• January 2010
• December 2009
• November 2009
• October 2009
• September 2009
• August 2009
• July 2009

Contact Us

1. Your Name(required)
2. Email(valid email required)
3. Message
4. Enter Text

 

cforms contact form by delicious:days

Recent Posts

• Bangor hospital ends free methadone program
• Two New Opiate Detox and Methadone Addiction Treatment Websites Launched by Meditox of Palm Beach
• C.A.R.E. Addiction Recovery Launches Counseling-Enhanced Detox Program
• Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
• Opiate addiction up, 1016 Recovery Network responds

Tags